Education
About Us
Working with TipRanks
Follow Us
BioAtla (BCAB)
NASDAQ:BCAB
Total Valuation
BioAtla has a market cap or net worth of $23.69M. The enterprise value is $109.62M.
Market Cap$23.69M
Enterprise Value$109.62M
Share Statistics
BioAtla has 58,418,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,418,140
Owned by Insiders9.17%
Owned by Institutions10.33%
Financial Efficiency
BioAtla’s return on equity (ROE) is -4.89 and return on invested capital (ROIC) is -190.98%.
Return on Equity (ROE)-4.89
Return on Assets (ROA)-1.33
Return on Invested Capital (ROIC)-190.98%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee180.33K
Profits Per Employee-1.14M
Employee Count61
Asset Turnover0.21
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioAtla is -0.41. BioAtla’s PEG ratio is 1.40.
PE Ratio-0.41
PS Ratio0.00
PB Ratio1.78
Price to Fair Value2.01
Price to FCF-3.54
Price to Operating Cash Flow-3.55
PEG Ratio1.40
Income Statement
In the last 12 months, BioAtla had revenue of 11.00M and earned -69.78M in profits. Earnings per share was -1.44.
Revenue11.00M
Gross Profit10.07M
Operating Income-73.94M
Pretax Income-69.78M
Net Income-69.78M
EBITDA-73.94M
Earnings Per Share (EPS)-1.44
Cash Flow
In the last 12 months, operating cash flow was -57.40M and capital expenditures 0.00, giving a free cash flow of -57.40M billion.
Operating Cash Flow-57.40M
Free Cash Flow-57.40M
Free Cash Flow per Share-0.98
Dividends & Yields
BioAtla pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.48
52-Week Price Change-74.36%
50-Day Moving Average0.41
200-Day Moving Average0.98
Relative Strength Index (RSI)44.13
Average Volume (3m)496.37K
Important Dates
BioAtla upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
BioAtla as a current ratio of 3.52, with Debt / Equity ratio of 2.21%
Current Ratio3.52
Quick Ratio3.52
Debt to Market Cap0.03
Net Debt to EBITDA0.65
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioAtla has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioAtla EV to EBITDA ratio is 0.26, with an EV/FCF ratio of 0.27.
EV to Sales-1.77
EV to EBITDA0.26
EV to Free Cash Flow0.27
EV to Operating Cash Flow0.27
Balance Sheet
BioAtla has $32.36M in cash and marketable securities with $554.00K in debt, giving a net cash position of -$31.81M billion.
Cash & Marketable Securities$32.36M
Total Debt$554.00K
Net Cash-$31.81M
Net Cash Per Share-$0.54
Tangible Book Value Per Share$0.29
Margins
Gross margin is 0.00%, with operating margin of -672.21%, and net profit margin of -634.33%.
Gross Margin0.00%
Operating Margin-672.21%
Pretax Margin-634.33%
Net Profit Margin-634.33%
EBITDA Margin-672.21%
EBIT Margin-672.21%
Analyst Forecast
The average price target for BioAtla is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.50
Price Target Upside1275.00% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast44.38%